222. 一次性ネフローゼ症候群 Primary nephrotic syndrome Clinical trials / Disease details

臨床試験数 : 285 / 薬物数 : 285 - (DrugBank : 108) / 標的遺伝子数 : 62 - 標的パスウェイ数 : 191

1 trial found

diseases per page:

Showing 1 to 1 of 1 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT00001959 (ClinicalTrials.gov)	December 1999	18/1/2000	Pirfenidone to Treat Kidney Disease (Focal Segmental Glomerulosclerosis)	Pirfenidone in Focal Segmental Glomerulosclerosis:Phase II Study	Fibrosis;Focal Glomerulosclerosis;Kidney Failure;Nephrotic Syndrome;Proteinuria	Drug: Pirfenidone	National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)	NULL	Completed	18 Years	N/A	All	21	Phase 2	United States

First Previous1Next Last